Over a month ago |
Hot Stocks
|
Oncocyte announced a… Oncocyte announced a reduction in force involving approximately 20% of its workforce, which management believes will extend Oncocyte's cash runway in 2024. "As part of our efforts to bring our cost structure in line with our kitted product strategy and to optimize our operational efficiency, we reduced our team by approximately 20%," said Joshua Riggs, CEO. "Those impacted have always put patients first in everything they do. We are grateful for their dedication and service to the clinical community." ShowHide Related Items >><< - 04/07/23
- OncoCyte announces peer-reviewed publication of DetermaIO study
- 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 04/04/23 Needham
- OncoCyte price target lowered to $0.45 from $1.40 at Needham
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 03/31/23
- OncoCyte reports preliminary FY22 revenue $5.6M, consensus $5.94M
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
|
Hot Stocks
|
Oncocyte announces the… Oncocyte announces the peer-reviewed publication of the results of a study applying DetermaIO to samples collected from the randomized Phase II AtezoTRIBE clinical trial in metastatic colorectal cancer. The results were published in Clinical Cancer Research and "showed the utility of DetermaIO in potentially identifying more responders to ICI therapy than current standard of care biomarkers," the company said in a statement. In the overall population of 122, DetermaIO positive patients achieved better outcomes in terms of progression-free survival from the addition of atezolizumab among mCRC patients than DetermaIO negative patients, regardless of MMR status, according to OncoCyte. A similar trend was observed in the pMMR population that does not currently qualify for ICI therapy in mCRC, it added. ShowHide Related Items >><< - 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 04/04/23 Needham
- OncoCyte price target lowered to $0.45 from $1.40 at Needham
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 03/31/23
- OncoCyte reports preliminary FY22 revenue $5.6M, consensus $5.94M
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
|
Recommendations
|
Needham lowered the… Needham lowered the firm's price target on OncoCyte to $0.45 from $1.40 and keeps a Buy rating on the shares. The analyst cites the company's Q4 revenue miss, though the firm also notes that OncoCyte has made significant progress in reducing cash burn from its reprioritization plan and expects further improvement in 2023. ShowHide Related Items >><< - 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 11/14/22 Piper Sandler
- OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
- 03/31/23
- OncoCyte reports preliminary FY22 revenue $5.6M, consensus $5.94M
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/29/23
- Global Partners to expand retail operations into Houston market
- 03/16/23
- Exxon Mobil launches $2B Beaumont refinery expansion
- 02/27/23
- Aris Water says ExxonMobil added to water reuse agreement
- 01/31/23
- Exxon Mobil reports Q4 cash flow from operating activities $18.95B
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/20/23
- TTEC Holdings CFO Dustin Semach to leave, Francois Bourret named interim CFO
- 01/11/23
- TTEC Holdings expands partnership with Google Cloud
- $194.67 /
-12.805 (-6.17%) - 04/02/23
- Fly Intel: Top five weekend stock stories
- 04/02/23
- Tesla reports Q1 deliveries of 422,875 on production of 440,808
- 03/31/23
- Tesla recalls 35 Semi trucks for parking brake issue
- 03/28/23
- NHTSA probing 50,000 Tesla Model Xs over seat belt malfunction
- $43.67 /
+7.125 (+19.50%) - 04/03/23
- Teck Resources rises 15.2%
- 04/03/23
- Teck Resources rises 14.8%
- 04/03/23
- Teck Resources rises 13.8%
- 04/03/23
- Teck Resources board rejects unsolicited acquisition proposal from Glencore
- 03/29/23
- Volta stockholders approve merger transaction with Shell USA
- 03/23/23
- Alaska Air signs agreement with Shell Aviation for sustainable aviation fuel
- 03/09/23
- Shell files Form 20-F with SEC
- 03/03/23
- Shell completes withdrawal from interest in Salym project in Russia
- 03/23/23
- SAIC to sell logistics and supply chain management arm to ASRC Federal
- 03/14/23
- Leidos protests Department of the Treasury TCloud award
- 02/24/23
- SAIC awarded $102.48M Navy contract modification
- 01/20/23
- SAIC launches new data science platform named Tenjin
- 10/20/22
- PPG sees Q4 tax rate 20%
- 10/19/22
- PPG names Tim Knavish as CEO, Michael McGarry as executive chairman
- 10/10/22
- PPG drops 6% to $107.00 after lowering Q3 EPS outlook
- 03/21/23
- Plug Power expands GenKey offering for warehouse with electric forklifts
- 03/02/23
- Plug Power announces 'historic flight' of airliner powered by ProGen fuel cells
- 02/21/23
- Plug Power, Acciona Energia present Valle H2V Navarra project
- 01/31/23
- Plug Power, Johnson Matthey announce long-term green hydrogen partnership
- 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 03/28/23
- Marqeta, WorkWhile announce partnership on new card solution
- 02/23/23
- Marqeta appoints Crystal Sumner as Chief Legal Officer
- 01/30/23
- Marqeta acquires Power Finance for $223M cash plus $52M milestone
- 01/26/23
- Marqeta names Simon Khalaf as CEO
- 03/29/23
- Macy's CEO: We've been working on the CEO transition plan for two years
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 02/16/23
- Life Storage board rejects unsolicited proposal from Public Storage
- 02/06/23
- Life Storage rises 12.7%
- 02/06/23
- Life Storage rises 10.9%
- 03/22/23
- Intel's Chief Architect Raja Koduri leaving after six years, says Gelsinger
- 03/21/23
- Intel appoints Stuart Pann as GM of Intel Foundry Services
- 03/06/23
- Intel delaying Falcon Shores to 2025, McVeigh says in blog post
- 02/22/23
- Intel provides update on effort to optimize cost structure
- 04/03/23
- Illumina to move expeditiously to divest GRAIL if it does not prevail in appeal
- 04/03/23
- Illumina sees resolution by late 2023, early 2024
- 04/03/23
- Illumina to appeal FTC decision in federal court
- 04/03/23
- FTC orders Illumina to divest cancer detection test maker GRAIL
- $117.72 /
+20.06 (+20.54%) - 04/03/23
- Mars to acquire Heska for $120.00 per share
- 04/03/23
- Mars to acquire Heska for $120.00 per share
- 01/09/23
- Heska CEO buys $646K in common stock
- 01/04/23
- Dalan Animal Health granted USDA conditional license for honeybee vaccine
- 03/21/23
- Texas Comptroller adds HSBC to energy sanctions list
- 03/20/23
- Bank of England issues statement, says U.K. banking system 'safe and sound'
- 03/13/23
- HSBC acquires Silicon Valley Bank UK for GBP 1
- 02/21/23
- HSBC sees RoTE of at least 12% for 2023 onwards
- 01/26/23
- Noranda Income Fund committee urges unitholders to vote for arrangement
- 01/13/23
- Noranda Income Fund committee 'convinced' privatization is in best interest
- 01/09/23
- Glencore Canada to acquire Noranda Income Fund priority units
- 03/30/23
- First Solar, EDP Renewables announce multi-year order for 1.8 gigawatts
- 03/29/23
- First Solar announces facility in India awarded financial incentives
- 03/01/23
- Origis Energy enters agreeent with First Solar for 2 GW of modules
- 02/28/23
- First Solar announces Lightsource bp places multi-year order for 4 GW
- $154.50 /
-8.515 (-5.22%) - 04/03/23
- Extra Space Storage falls 7% in pre-market after confirming Life Storage deal
- 04/03/23
- Extra Space Storage to acquire Life Storage in an all-stock transaction
- 02/16/23
- Extra Space Storage increases quarterly dividend 8% to $1.62 per share
- 04/03/23
- WWE: WrestleMania 39 was highest-grossing event in company history
- 04/03/23
- Endeavor CEO won't have any input on creative process, Emanual says
- 04/03/23
- Endeavor CEO: I would not let WWE's Vince McMahon step aside
- 04/03/23
- Endeavor CEO Ari Emanual tells CNBC WWE deal is win-win
- 03/06/23
- Air Lease announces lease placement of 3 new Airbus A350-900 with Air France
- 02/15/23
- Airbus names Covestro's Thomas Toepfer as new CFO
- 02/14/23
- GE Aerospace announces firm order for 40 GEnx-1B, 20 GE9X engines from Air India
- 02/06/23
- Air Transport Services backs prior FY22 view, CAM unit completes conversions
- 03/30/23
- Marathon Oil to further develop Equatorial Guinea gas mega hub
- 03/14/23
- Corteva, Bunge, Chevron team to produce lower carbon winter canola
- 03/13/23
- Emerson selected to automate Golden Triangle Polymers facility
- 03/07/23
- Chevron, JERA sign MOU to explore carbon capture projects in U.S., Australia
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- $108.37 /
+9.155 (+9.23%) - 03/27/23
- Brookfield Renewable, EIG Consortium to acquire Origin Energy for $18.7B
- 03/27/23
- ConocoPhillips to purchase additional 2.49% interest in APLNG for $500M
- 03/20/23
- Sempra Energy launches Port Arthur LNG project
- 03/13/23
- ConocoPhillips 'welcomes' record of decision on Willow project
- 04/03/23
- Sternlicht group seeks change at Cano Health, including replacement of CEO
- 03/31/23
- Cano Health 'disappointed that three directors chose to resign'
- 03/30/23
- Cano Health's Barry Sternlicht resigns from board
- 02/14/23
- Third Point buys AIG, exits T-Mobile in Q4
- 04/03/23
- TravelCenters files definitive proxy statement for BP Products transaction
- 03/29/23
- Arko says 'riskless' to TravelCenters' holders for board to engage on proposal
- 03/28/23
- TravelCenters confirms ARKO proposal not superior to BP transaction
- 03/27/23
- ARKO urges Travel Centers board to consider acquisition proposal
- 11/16/22
- BGC Partners enters Corporate Conversion Agreement, changing name, ticker
- 04/03/23
- A10 Networks falls -10.3%
- 11/02/22
- A10 Networks raises dividend, announces new $50M buyback
- $72.81 /
-34.17 (-31.94%) - 04/03/23
- Ascendis Pharma falls 38% after disclosing FDA notice of deficiencies in NDA
- 04/03/23
- Ascendis' Phase 1/2 initial trial results of TransCon accepted for ASCO 2023
- 04/03/23
- Ascendis announces FDA notified it of deficiencies in NDA for TransCon PTH
- 01/04/23
- Ascendis Pharma announces online portal open to request access to TransCon PTH
- $76.68 /
+10.67 (+16.16%) - 03/15/23
- Apellis: FDA extends PDUFA goal date for sNDA for Empaveli Injector
- 02/17/23
- Apellis Pharmaceuticals trading resumes
- 02/17/23
- Apellis says FDA approves SYFOVRE for GA treatment
- 02/17/23
- Iveric bio rallies 23% to $24.70 after FDA approves Apellis drug
- 03/15/23
- Atlas Energy founder buys $5.04M in common stock
- 04/04/23 Benchmark
- Benchmark downgrades WWE to Hold, doesn't see bidders beyond Endeavor
- 04/04/23 Deutsche Bank
- Deutsche Bank likes Endeavor's combination with WWE
- 04/03/23 Wells Fargo
- WWE, UFC reported deal implies $102/share, says Wells Fargo
- 03/13/23 Deutsche Bank
- Endeavor one of the best positioned media companies, says Deutsche Bank
- 04/04/23 Benchmark
- WWE downgraded to Hold from Buy at Benchmark
- $194.67 /
-12.805 (-6.17%) - 04/03/23 BofA
- Tesla sales growth 'lighter than hoped' in Q1, says BofA
- 04/03/23 Deutsche Bank
- Tesla's Q1 deliveries slightly better than consensus, says Deutsche Bank
- 04/03/23 TD Cowen
- Tesla price target raised to $170 from $140 at TD Cowen
- 04/03/23 Baird
- Tesla yealry production number biased to upside, says Baird
- $154.50 /
-8.515 (-5.22%) - 04/03/23 Truist
- Truist does not think will be offer superior to Extra Space's for Life Storage
- 04/03/23 BMO Capital
- BMO 'can't rule out a topping bid' for Life Storage after Extra Space agreement
- 03/27/23 Evercore ISI
- Evercore sees challenges for office REIT, reaffirms Extra Space price target
- 03/08/23 Truist
- Extra Space Storage price target raised to $165 from $160 at Truist
- 03/08/23 Truist
- Life Storage price target raised to $120 from $115 at Truist
- 02/08/23 Citi
- Life Storage downgraded to Neutral from Buy at Citi
- $117.72 /
+20.06 (+20.54%) - 04/03/23 Morgan Stanley
- Heska upgraded to Equal Weight from Underweight at Morgan Stanley
- 04/03/23 Alliance Global Partners
- Heska downgraded to Neutral from Buy at Alliance Global Partners
- 03/02/23 Piper Sandler
- Heska price target lowered to $150 from $165 at Piper Sandler
- 03/01/23 Alliance Global Partners
- Heska price target raised to $129 from $119 at Alliance Global Partners
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 04/03/23 Bernstein
- Intel upgraded to Market Perform from Underperform at Bernstein
- 03/30/23 Deutsche Bank
- Intel price target raised to $32 from $28 at Deutsche Bank
- 03/30/23 Morgan Stanley
- Intel data center and AI webinar had 'no big surprises,' says Morgan Stanley
- 03/30/23 Raymond James
- Intel price target raised to $35 from $33 at Raymond James
- 04/03/23 JPMorgan
- Macy's upgraded to Overweight from Neutral at JPMorgan
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 04/03/23 Morgan Stanley
- First Solar downgraded to Underweight from Equal Weight at Morgan Stanley
- 03/23/23 Barclays
- First Solar price target raised to $230 from $162 at Barclays
- 03/15/23 Credit Suisse
- First Solar price target raised to $163 from $152 at Credit Suisse
- 03/14/23 Argus
- First Solar price target raised to $261 from $176 at Argus
- 04/04/23 Citi
- Atlas Energy initiated with a Buy at Citi
- 04/04/23 Capital One
- Atlas Energy initiated with an Overweight at Capital One
- 04/03/23 BofA
- Atlas Energy initiated with a Buy at BofA
- 04/03/23 Piper Sandler
- Atlas Energy initiated with Overweight, $28 target at Piper Sandler
- 04/03/23 Morgan Stanley
- Marqeta downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/29/23 Mizuho
- Marqeta price target lowered to $7 from $8 at Mizuho
- 03/27/23 Wolfe Research
- Marqeta upgraded to Outperform from Peer Perform at Wolfe Research
- 03/02/23 Barclays
- Marqeta price target lowered to $6 from $10 at Barclays
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 02/28/23 JPMorgan
- HSBC price target raised to 650 GBp from 570 GBp at JPMorgan
- 02/24/23 RBC Capital
- HSBC price target raised to 775 GBp from 750 GBp at RBC Capital
- 02/23/23 Berenberg
- HSBC price target raised to 780 GBp from 625 GBp at Berenberg
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 02/07/23 Berenberg
- Airbus downgraded to Sell from Hold at Berenberg
- 01/31/23 UBS
- Airbus downgraded to Sell from Buy at UBS
- 01/27/23 Kepler Cheuvreux
- Airbus downgraded to Reduce from Hold at Kepler Cheuvreux
- 01/26/23 Jefferies
- Airbus downgraded to Hold from Buy at Jefferies
- 04/04/23 Exane BNP Paribas
- Chevron upgraded to Neutral from Underperform at Exane BNP Paribas
- 03/27/23 Morgan Stanley
- Chevron price target lowered to $192 from $195 at Morgan Stanley
- 03/10/23 Mizuho
- Chevron price target raised to $206 from $200 at Mizuho
- 03/02/23 Wells Fargo
- Chevron price target lowered to $199 from $204 at Wells Fargo
- 03/21/23 Morgan Stanley
- BP price target lowered to 605 GBp from 660 GBp at Morgan Stanley
- 02/24/23 JPMorgan
- BP price target raised to 585 GBp from 540 GBp at JPMorgan
- 02/23/23 Berenberg
- BP downgraded to Hold from Buy at Berenberg
- 02/17/23 BMO Capital
- TravelCenters price target raised to $86 from $60 at BMO Capital
- $108.37 /
+9.155 (+9.23%) - 03/27/23 Morgan Stanley
- ConocoPhillips price target lowered to $115 from $122 at Morgan Stanley
- 03/23/23 Barclays
- ConocoPhillips price target lowered to $141 from $160 at Barclays
- 03/10/23 Mizuho
- ConocoPhillips price target lowered to $143 from $150 at Mizuho
- 02/27/23 Citi
- ConocoPhillips price target lowered to $145 from $160 at Citi
- 03/30/23 Deutsche Bank
- Shell price target lowered to 2,854 GBp from 2,987 GBp at Deutsche Bank
- 03/21/23 Morgan Stanley
- Shell price target lowered to 2,405 GBp from 2,625 GBp at Morgan Stanley
- 02/28/23 AlphaValue/Baader
- Shell upgraded to Add from Reduce at AlphaValue/Baader
- 02/26/23 Goldman Sachs
- Shell upgraded to Buy from Neutral at Goldman Sachs
- 03/02/23 Barrington
- TTEC Holdings downgraded to Market Perform from Outperform at Barrington
- 03/01/23 Craig-Hallum
- TTEC Holdings price target lowered to $50 from $60 at Craig-Hallum
- 03/01/23 Canaccord
- TTEC Holdings price target lowered to $80 from $100 at Canaccord
- 03/01/23 TD Cowen
- TTEC Holdings price target lowered to $42 from $44 at Cowen
- 03/28/23 Morgan Stanley
- Morgan Stanley adjusts 'Fresh Money Buy List' to position more defensively
- 03/10/23 Mizuho
- Exxon Mobil price target raised to $147 from $140 at Mizuho
- 03/03/23 Wells Fargo
- Exxon Mobil price target raised to $133 from $125 at Wells Fargo
- 02/02/23 Argus
- Exxon Mobil price target raised to $133 from $128 at Argus
- 04/03/23 Citi
- Citi not dismissing Cano investor group's ability to enact change
- 01/06/23 UBS
- Cano Health downgraded to Neutral from Buy at UBS
- 01/05/23 Wolfe Research
- Cano Health downgraded to Peer Perform from Outperform at Wolfe Research
- 12/13/22 Citi
- Citi opens 'positive Catalyst Watch' on Cano Health
- $43.67 /
+7.125 (+19.50%) - 04/04/23 B. Riley
- Teck Resources upgraded to Buy from Neutral at B. Riley
- 04/03/23 BofA
- Teck Resources price target lowered to C$62 from C$65 at BofA
- 03/29/23 Morgan Stanley
- Teck Resources price target lowered to $42 from $44 at Morgan Stanley
- 03/14/23 Scotiabank
- Teck Resources price target raised to C$75 from C$70 at Scotiabank
- 03/30/23 Morgan Stanley
- Glencore price target lowered to 602 GBp from 670 GBp at Morgan Stanley
- 03/20/23 BofA
- Glencore upgraded to Buy from Neutral at BofA
- 03/20/23 UBS
- Glencore upgraded to Buy from Neutral at UBS
- 03/13/23 JPMorgan
- Glencore price target lowered to 620 GBp from 630 GBp at JPMorgan
- $76.68 /
+10.67 (+16.16%) - 03/09/23 Citi
- Apellis price target lowered to $88 from $91 at Citi
- 02/22/23 Raymond James
- Apellis price target raised to $139 from $123 at Raymond James
- 02/21/23 H.C. Wainwright
- H.C. Wainwright says Belite Bio opportunity intact despite GA treatment approval
- 02/21/23 BofA
- Apellis price target raised to $115 from $79 at BofA
- $72.81 /
-34.17 (-31.94%) - 04/04/23 Morgan Stanley
- Ascendis Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
- 04/03/23 BofA
- Ascendis Pharma price target lowered to $92 from $132 at BofA
- 04/03/23 Credit Suisse
- Ascendis Pharma downgraded at Credit Suisse after FDA find deficiencies in NDA
- 04/03/23 Credit Suisse
- Ascendis Pharma downgraded to Neutral from Outperform at Credit Suisse
- 04/03/23 Morgan Stanley
- Plug Power downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/05/23 Citi
- Plug Power price target lowered to $20 from $21 at Citi
- 03/02/23 Piper Sandler
- Plug Power price target lowered to $17 from $20 at Piper Sandler
- 03/02/23 KeyBanc
- Plug Power price target lowered to $25 from $31 at KeyBanc
- 04/04/23 Baird
- PPG well positioned and remains a Top Pick, says Baird
- 04/04/23 Morgan Stanley
- PPG price target raised to $140 from $120 at Morgan Stanley
- 04/03/23 Credit Suisse
- PPG price target raised to $128 from $118 at Credit Suisse
- 01/30/23 Deutsche Bank
- Axalta Coating upgraded to Buy from Hold at Deutsche Bank
- 04/04/23 BTIG
- A10 Networks initiated with a Neutral at BTIG
- 11/02/22 BWS Financial
- A10 Networks price target raised to $24 from $20 at BWS Financial
- 04/04/23 Citi
- SAIC price target lowered to $127 from $141 at Citi
- 03/30/23 William Blair
- William Blair learned Verizon teaming with SAIC on big FAA contract
- 01/03/23 Morgan Stanley
- SAIC downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/09/22 Morgan Stanley
- SAIC price target raised to $108 from $99 at Morgan Stanley
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 11/14/22 Piper Sandler
- OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79
- 02/02/23
- WWE reports Q4 EPS 45c, consensus 58c
- 11/02/22
- WWE reports Q3 EPS 49c, consensus 50c
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 02/27/23
- TTEC Holdings sees FY23 EPS $2.38-$2.71, consensus $3.75
- 02/27/23
- TTEC Holdings sees Q1 EPS 41c-54c, consensus 81c
- 02/27/23
- TTEC Holdings reports Q4 EPS 89c, consensus 74c
- 11/09/22
- TTEC Holdings sees FY22 non-GAAP EPS $3.45-$3.61, consensus $3.54
- $194.67 /
-12.805 (-6.17%) - 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- $43.67 /
+7.125 (+19.50%) - 02/21/23
- Teck Resources reports Q4 adjusted EPS C$1.07 vs. C$2.54 a year ago
- 10/27/22
- Teck Resources reports Q3 adjusted EPS C$1.74 vs. C$1.88 last year
- 02/02/23
- Shell reports Q4 adjusted EPS $1.39 vs. 83c last year
- 10/27/22
- Shell reports Q3 adjusted EPS $1.30 vs. 53c last year
- 04/03/23
- SAIC guides FY24 EPS $6.80-$7.00, consensus $7.48
- 04/03/23
- SAIC reports Q4 EPS $2.04, consensus $1.66
- 12/05/22
- SAIC raises FY23 adjusted EPS view to $7.05-$7.20 from $7.00-$7.20
- 12/05/22
- SAIC reports Q3 EPS $1.90, consensus $1.74
- 04/03/23
- PPG raises Q1 adjusted EPS view to $1.52-$1.58 from $1.10-$1.20, consensus $1.18
- 01/19/23
- PPG sees Q1 adjusted EPS $1.10-$1.20, consensus $1.36
- 01/19/23
- PPG Industries reports Q4 adjusted EPS $1.22, consensus $1.13
- 10/19/22
- PPG sees Q4 adjusted EPS $1.05-$1.20, consensus $1.25
- 03/01/23
- Plug Power sees FY23 revenue $1.4B, consensus $1.37B
- 03/01/23
- Plug Power reports Q4 revenue $220.7M, consensus $277.28M
- 03/01/23
- Notable companies reporting after market close
- 01/25/23
- Plug Power sees FY23 revenue at $1.4B, consensus $1.37B
- 03/31/23
- OncoCyte reports preliminary FY22 revenue $5.6M, consensus $5.94M
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
- 02/28/23
- Marqeta sees Q1 net revenue growth 26%-28%, consensus $214.08M
- 02/28/23
- Marqeta reports Q4 EPS (5c), consensus (9c)
- 11/09/22
- Marqeta sees Q4 revenue up 29%-31%, consensus $191M
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/23/23
- Life Storage sees FY23 AFFO $6.75-$6.95, consensus $6.98
- 02/23/23
- Life Storage sees Q1 AFFO $1.55-$1.59
- 02/23/23
- Life Storage reports Q4 AFFO $1.69, consensus $1.64
- 11/02/22
- Life Storage sees Q4 FFO $1.60-$.64
- 02/22/23
- Intel backs Q1 EPS view (15c), consensus (15c)
- 02/16/23
- Tower Semiconductor not providing Q1 revenue guidance
- 01/26/23
- Intel sees Q1 EPS (15c), consensus 24c
- 01/26/23
- Intel reports Q4 EPS 10c, consensus 20c
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- $117.72 /
+20.06 (+20.54%) - 02/28/23
- Heska sees FY23 revenue growth 8%-12%, consensus $278.56M
- 02/28/23
- Heska reports Q4 adjusted EPS 55c, consensus (4c)
- 11/08/22
- Heska reports Q4 non-GAAP EPS 41c, consensus (11c)
- 02/21/23
- HSBC reports FY22 EPS 74c vs. 62c last year
- 10/25/22
- HSBC reports Q3 EPS 10c vs. 17c last year
- 11/22/22
- Mechel announces amendment to agreement with Glencore
- 02/28/23
- First Solar sees FY23 EPS $7.00-$8.00, consensus $4.77
- 02/28/23
- First Solar reports Q4 EPS (7c), consensus (15c)
- 02/28/23
- Notable companies reporting after market close
- 10/27/22
- First Solar reports Q3 EPS (46c), consensus (27c)
- $154.50 /
-8.515 (-5.22%) - 02/22/23
- Extra Space Storage sees 2023 core FFO $8.30-$8.60 vs. $8.44 in 2022
- 02/22/23
- Extra Space Storage reports Q4 core FFO $2.09 vs. $1,91 a year ago
- 11/01/22
- Extra Space Storage narrows FY22 core FFO $8.30-$8.40 from $8.30-$8.50
- 11/01/22
- Extra Space Storage reports Q3 core FFO $2.21, consensus $2.18
- 02/28/23
- Endeavor Group sees Fy23 revenue $5.825B-$5.975B, consensus $5.81B
- 02/28/23
- Endeavor Group reports Q4 EPS (72c) vs (7c) last year
- 11/10/22
- Endeavor cuts FY22 revenue view to $5.235B-$5.325B, consensus $5.36B
- 11/10/22
- Endeavor reports Q3 EPS (4c), consensus 29c
- 02/16/23
- Airbus sees FY23 EBIT adjusted EUR 6B
- 02/16/23
- Airbus reports FY22 revenue EUR 58.8B, EBIT adjusted up 16% to EUR 5.6B
- 10/28/22
- Airbus reports Q3 revenue EUR 38.1B, EBIT adjusted EUR 3.5B
- 01/27/23
- Chevron reports Q4 adjusted EPS $4.09, consensus $4.38
- 01/26/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Chevron reports Q3 adjusted EPS $5.56, consensus $4.81
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- $108.37 /
+9.155 (+9.23%) - 02/02/23
- ConocoPhillips reports Q4 EPS $2.71, consensus $2.81
- 11/03/22
- ConocoPhillips reports Q3 EPS $3.60, consensus $3.44
- 11/02/22
- Notable companies reporting before tomorrow's open
- 03/01/23
- Cano Health sees FY23 revenue $3.1B-43.25B, consensus $3.26B
- 03/01/23
- Cano Health reports Q4 EPS (61c), consensus (13c)
- 11/09/22
- Cano Health lowers FY22 revenue view to $2.70B-$2.75B from $2.85B-$2.90B
- 11/09/22
- Cano Health reports Q3 EPS (23c), consensus (5c)
- 02/07/23
- BP reports Q4 EPS $1.59, consensus $1.67
- 11/01/22
- BP reports Q3 EPS $2.59, consensus $1.94
- 03/31/23
- BGC Partners says Q1 revenue impacted by recent turmoil across regional banks
- 02/27/23
- BGC Partners sees Q1 revenue $515M-$565M
- 02/27/23
- BGC Partners reports Q4 adjusted EPS 16c vs 17c last year
- 12/30/22
- BGC Partners sees Q4 adjusted earnings above midpoint of previous outlook
- 04/03/23
- A10 Networks backs prior FY23 double-digit growth view for EPS
- 04/03/23
- A10 Networks sees Q1 revenue $56 M-$58M, consensus $66.05M
- 02/07/23
- A10 Networks reports Q4 EPS 24c, two estimates 22c
- 11/01/22
- A10 Networks backs FY22 revenue growth target of 10%-12%
- $72.81 /
-34.17 (-31.94%) - 11/02/22
- Ascendis Pharma reports Q3 EPS ( EUR 3.03) vs. (EUR 1.47) last year
- $76.68 /
+10.67 (+16.16%) - 02/21/23
- Apellis reports Q4 EPS ($1.50), consensus ($1.57)
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/29/23
- Global Partners to expand retail operations into Houston market
- 03/16/23
- Exxon Mobil launches $2B Beaumont refinery expansion
- 02/27/23
- Aris Water says ExxonMobil added to water reuse agreement
- 01/31/23
- Exxon Mobil reports Q4 cash flow from operating activities $18.95B
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 11/23/22
- EC proposes new EU instrument to blunt excessive gas price spikes
- 11/15/22
- TotalEnergies completes acquisition of Hess 8.16% interest Waha concession
- $194.03 /
-13.445 (-6.48%) - 04/02/23
- Fly Intel: Top five weekend stock stories
- 04/02/23
- Tesla reports Q1 deliveries of 422,875 on production of 440,808
- 03/31/23
- Tesla recalls 35 Semi trucks for parking brake issue
- 03/28/23
- NHTSA probing 50,000 Tesla Model Xs over seat belt malfunction
- $41.97 /
+5.425 (+14.84%) - 04/03/23
- Teck Resources rises 15.2%
- 04/03/23
- Teck Resources rises 14.8%
- 04/03/23
- Teck Resources rises 13.8%
- 04/03/23
- Teck Resources board rejects unsolicited acquisition proposal from Glencore
- 03/31/23
- First Citizens reports FDIC exercises $500M appreciation right in SVB deal
- 03/27/23
- FDIC investigating misconduct in management of SVB Financial, Signature Bank
- 03/27/23
- First Citizens 'encouraged' by SVB's strong underwriting
- 03/27/23
- First Citizens: Capital ratios remains robust after SVB pact
- 03/29/23
- Volta stockholders approve merger transaction with Shell USA
- 03/23/23
- Alaska Air signs agreement with Shell Aviation for sustainable aviation fuel
- 03/09/23
- Shell files Form 20-F with SEC
- 03/03/23
- Shell completes withdrawal from interest in Salym project in Russia
- 03/23/23
- SAIC to sell logistics and supply chain management arm to ASRC Federal
- 03/14/23
- Leidos protests Department of the Treasury TCloud award
- 02/24/23
- SAIC awarded $102.48M Navy contract modification
- 01/20/23
- SAIC launches new data science platform named Tenjin
- 10/20/22
- PPG sees Q4 tax rate 20%
- 10/19/22
- PPG names Tim Knavish as CEO, Michael McGarry as executive chairman
- 10/10/22
- PPG drops 6% to $107.00 after lowering Q3 EPS outlook
- 03/21/23
- Plug Power expands GenKey offering for warehouse with electric forklifts
- 03/02/23
- Plug Power announces 'historic flight' of airliner powered by ProGen fuel cells
- 02/21/23
- Plug Power, Acciona Energia present Valle H2V Navarra project
- 01/31/23
- Plug Power, Johnson Matthey announce long-term green hydrogen partnership
- 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 03/28/23
- Marqeta, WorkWhile announce partnership on new card solution
- 02/23/23
- Marqeta appoints Crystal Sumner as Chief Legal Officer
- 01/30/23
- Marqeta acquires Power Finance for $223M cash plus $52M milestone
- 01/26/23
- Marqeta names Simon Khalaf as CEO
- 03/29/23
- McDonald's: Robert Eckert and John Rogers, Jr. to retire from board
- 03/27/23
- ATI Physical Therapy announces partnership with McDonald's All American Games
- 03/20/23
- Oatly Group brings Oatly Barista to all McDonald's McCafe locations in Austria
- 03/29/23
- Macy's CEO: We've been working on the CEO transition plan for two years
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/22/23
- Intel's Chief Architect Raja Koduri leaving after six years, says Gelsinger
- 03/21/23
- Intel appoints Stuart Pann as GM of Intel Foundry Services
- 03/06/23
- Intel delaying Falcon Shores to 2025, McVeigh says in blog post
- 02/22/23
- Intel provides update on effort to optimize cost structure
- $117.73 /
+20.07 (+20.55%) - 04/03/23
- Mars to acquire Heska for $120.00 per share
- 04/03/23
- Mars to acquire Heska for $120.00 per share
- 01/09/23
- Heska CEO buys $646K in common stock
- 01/04/23
- Dalan Animal Health granted USDA conditional license for honeybee vaccine
- 03/21/23
- Texas Comptroller adds HSBC to energy sanctions list
- 03/20/23
- Bank of England issues statement, says U.K. banking system 'safe and sound'
- 03/13/23
- HSBC acquires Silicon Valley Bank UK for GBP 1
- 02/21/23
- HSBC sees RoTE of at least 12% for 2023 onwards
- 01/26/23
- Noranda Income Fund committee urges unitholders to vote for arrangement
- 01/13/23
- Noranda Income Fund committee 'convinced' privatization is in best interest
- 01/09/23
- Glencore Canada to acquire Noranda Income Fund priority units
- 03/30/23
- First Solar, EDP Renewables announce multi-year order for 1.8 gigawatts
- 03/29/23
- First Solar announces facility in India awarded financial incentives
- 03/01/23
- Origis Energy enters agreeent with First Solar for 2 GW of modules
- 02/28/23
- First Solar announces Lightsource bp places multi-year order for 4 GW
- $155.44 /
-7.575 (-4.65%) - 04/03/23
- Extra Space Storage falls 7% in pre-market after confirming Life Storage deal
- 04/03/23
- Extra Space Storage to acquire Life Storage in an all-stock transaction
- 02/16/23
- Extra Space Storage increases quarterly dividend 8% to $1.62 per share
- 04/03/23
- WWE: WrestleMania 39 was highest-grossing event in company history
- 04/03/23
- Endeavor CEO won't have any input on creative process, Emanual says
- 04/03/23
- Endeavor CEO: I would not let WWE's Vince McMahon step aside
- 04/03/23
- Endeavor CEO Ari Emanual tells CNBC WWE deal is win-win
- 03/06/23
- Air Lease announces lease placement of 3 new Airbus A350-900 with Air France
- 02/15/23
- Airbus names Covestro's Thomas Toepfer as new CFO
- 02/14/23
- GE Aerospace announces firm order for 40 GEnx-1B, 20 GE9X engines from Air India
- 02/06/23
- Air Transport Services backs prior FY22 view, CAM unit completes conversions
- 03/30/23
- Marathon Oil to further develop Equatorial Guinea gas mega hub
- 03/14/23
- Corteva, Bunge, Chevron team to produce lower carbon winter canola
- 03/13/23
- Emerson selected to automate Golden Triangle Polymers facility
- 03/07/23
- Chevron, JERA sign MOU to explore carbon capture projects in U.S., Australia
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- $107.11 /
+7.895 (+7.96%) - 03/27/23
- Brookfield Renewable, EIG Consortium to acquire Origin Energy for $18.7B
- 03/27/23
- ConocoPhillips to purchase additional 2.49% interest in APLNG for $500M
- 03/20/23
- Sempra Energy launches Port Arthur LNG project
- 03/13/23
- ConocoPhillips 'welcomes' record of decision on Willow project
- 04/03/23
- Sternlicht group seeks change at Cano Health, including replacement of CEO
- 03/31/23
- Cano Health 'disappointed that three directors chose to resign'
- 03/30/23
- Cano Health's Barry Sternlicht resigns from board
- 02/14/23
- Third Point buys AIG, exits T-Mobile in Q4
- 04/03/23
- TravelCenters files definitive proxy statement for BP Products transaction
- 03/29/23
- Arko says 'riskless' to TravelCenters' holders for board to engage on proposal
- 03/28/23
- TravelCenters confirms ARKO proposal not superior to BP transaction
- 03/27/23
- ARKO urges Travel Centers board to consider acquisition proposal
- 11/16/22
- BGC Partners enters Corporate Conversion Agreement, changing name, ticker
- 04/03/23
- A10 Networks falls -10.3%
- 11/02/22
- A10 Networks raises dividend, announces new $50M buyback
- $73.71 /
-33.27 (-31.10%) - 04/03/23
- Ascendis Pharma falls 38% after disclosing FDA notice of deficiencies in NDA
- 04/03/23
- Ascendis' Phase 1/2 initial trial results of TransCon accepted for ASCO 2023
- 04/03/23
- Ascendis announces FDA notified it of deficiencies in NDA for TransCon PTH
- 01/04/23
- Ascendis Pharma announces online portal open to request access to TransCon PTH
- 03/15/23
- Apellis: FDA extends PDUFA goal date for sNDA for Empaveli Injector
- 02/17/23
- Apellis Pharmaceuticals trading resumes
- 02/17/23
- Apellis says FDA approves SYFOVRE for GA treatment
- 02/17/23
- Iveric bio rallies 23% to $24.70 after FDA approves Apellis drug
- 03/15/23
- Atlas Energy founder buys $5.04M in common stock
- 04/03/23 Bernstein
- Intel upgraded to Market Perform from Underperform at Bernstein
- 03/30/23 Deutsche Bank
- Intel price target raised to $32 from $28 at Deutsche Bank
- 03/30/23 Morgan Stanley
- Intel data center and AI webinar had 'no big surprises,' says Morgan Stanley
- 03/30/23 Raymond James
- Intel price target raised to $35 from $33 at Raymond James
- 04/03/23 JPMorgan
- Macy's upgraded to Overweight from Neutral at JPMorgan
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 04/03/23 Morgan Stanley
- First Solar downgraded to Underweight from Equal Weight at Morgan Stanley
- 03/23/23 Barclays
- First Solar price target raised to $230 from $162 at Barclays
- 03/15/23 Credit Suisse
- First Solar price target raised to $163 from $152 at Credit Suisse
- 03/14/23 Argus
- First Solar price target raised to $261 from $176 at Argus
- 04/03/23 Morgan Stanley
- Marqeta downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/29/23 Mizuho
- Marqeta price target lowered to $7 from $8 at Mizuho
- 03/27/23 Wolfe Research
- Marqeta upgraded to Outperform from Peer Perform at Wolfe Research
- 03/02/23 Barclays
- Marqeta price target lowered to $6 from $10 at Barclays
- 04/03/23 BofA
- Atlas Energy initiated with a Buy at BofA
- 04/03/23 Piper Sandler
- Atlas Energy initiated with Overweight, $28 target at Piper Sandler
- 04/03/23 Raymond James
- Atlas Energy initiated with a Strong Buy at Raymond James
- 04/03/23 Piper Sandler
- Atlas Energy initiated with an Overweight at Piper Sandler
- 04/03/23 Wells Fargo
- WWE, UFC reported deal implies $102/share, says Wells Fargo
- 03/13/23 Deutsche Bank
- Endeavor one of the best positioned media companies, says Deutsche Bank
- 08/29/22 Credit Suisse
- Endeavor Group price target lowered to $33 from $40 at Credit Suisse
- 08/04/22 BofA
- BofA starts 'well positioned' Endeavor Group at Buy
- 02/03/23 Guggenheim
- WWE price target raised to $105 from $94 at Guggenheim
- 02/03/23 Benchmark
- WWE price target raised to $95 from $86 at Benchmark
- 01/31/23 Wolfe Research
- Wolfe Research says WWE not downgraded in correction note
- $194.03 /
-13.445 (-6.48%) - 04/03/23 BofA
- Tesla sales growth 'lighter than hoped' in Q1, says BofA
- 04/03/23 Deutsche Bank
- Tesla's Q1 deliveries slightly better than consensus, says Deutsche Bank
- 04/03/23 TD Cowen
- Tesla price target raised to $170 from $140 at TD Cowen
- 04/03/23 Baird
- Tesla yealry production number biased to upside, says Baird
- $155.44 /
-7.575 (-4.65%) - 04/03/23 Truist
- Truist does not think will be offer superior to Extra Space's for Life Storage
- 04/03/23 BMO Capital
- BMO 'can't rule out a topping bid' for Life Storage after Extra Space agreement
- 03/27/23 Evercore ISI
- Evercore sees challenges for office REIT, reaffirms Extra Space price target
- 03/08/23 Truist
- Extra Space Storage price target raised to $165 from $160 at Truist
- 03/21/23 Morgan Stanley
- BP price target lowered to 605 GBp from 660 GBp at Morgan Stanley
- 02/24/23 JPMorgan
- BP price target raised to 585 GBp from 540 GBp at JPMorgan
- 02/23/23 Berenberg
- BP downgraded to Hold from Buy at Berenberg
- 02/17/23 BMO Capital
- TravelCenters price target raised to $86 from $60 at BMO Capital
- $107.11 /
+7.895 (+7.96%) - 03/27/23 Morgan Stanley
- ConocoPhillips price target lowered to $115 from $122 at Morgan Stanley
- 03/23/23 Barclays
- ConocoPhillips price target lowered to $141 from $160 at Barclays
- 03/10/23 Mizuho
- ConocoPhillips price target lowered to $143 from $150 at Mizuho
- 02/27/23 Citi
- ConocoPhillips price target lowered to $145 from $160 at Citi
- 03/30/23 Deutsche Bank
- Shell price target lowered to 2,854 GBp from 2,987 GBp at Deutsche Bank
- 03/21/23 Morgan Stanley
- Shell price target lowered to 2,405 GBp from 2,625 GBp at Morgan Stanley
- 02/28/23 AlphaValue/Baader
- Shell upgraded to Add from Reduce at AlphaValue/Baader
- 02/26/23 Goldman Sachs
- Shell upgraded to Buy from Neutral at Goldman Sachs
- 03/21/23 Morgan Stanley
- TotalEnergies upgraded to Overweight from Equal Weight at Morgan Stanley
- 02/09/23 Morgan Stanley
- TotalEnergies price target raised to EUR 66 from EUR 60 at Morgan Stanley
- 01/23/23 Morgan Stanley
- TotalEnergies price target lowered to EUR 60 from EUR 65 at Morgan Stanley
- 01/19/23 JPMorgan
- TotalEnergies price target raised to EUR 73 from EUR 68 at JPMorgan
- 03/28/23 Morgan Stanley
- Morgan Stanley adjusts 'Fresh Money Buy List' to position more defensively
- 03/10/23 Mizuho
- Exxon Mobil price target raised to $147 from $140 at Mizuho
- 03/03/23 Wells Fargo
- Exxon Mobil price target raised to $133 from $125 at Wells Fargo
- 02/02/23 Argus
- Exxon Mobil price target raised to $133 from $128 at Argus
- 03/27/23 Morgan Stanley
- Chevron price target lowered to $192 from $195 at Morgan Stanley
- 03/10/23 Mizuho
- Chevron price target raised to $206 from $200 at Mizuho
- 03/02/23 Wells Fargo
- Chevron price target lowered to $199 from $204 at Wells Fargo
- 02/24/23 TD Cowen
- Chevron price target lowered to $170 from $185 at Cowen
- $117.73 /
+20.07 (+20.55%) - 03/02/23 Piper Sandler
- Heska price target lowered to $150 from $165 at Piper Sandler
- 03/01/23 Alliance Global Partners
- Heska price target raised to $129 from $119 at Alliance Global Partners
- 01/06/23 Morgan Stanley
- Heska downgraded to Underweight at Morgan Stanley on risk to 2023 growth
- 01/06/23 Morgan Stanley
- Heska downgraded to Underweight from Equal Weight at Morgan Stanley
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 02/28/23 JPMorgan
- HSBC price target raised to 650 GBp from 570 GBp at JPMorgan
- 02/24/23 RBC Capital
- HSBC price target raised to 775 GBp from 750 GBp at RBC Capital
- 02/23/23 Berenberg
- HSBC price target raised to 780 GBp from 625 GBp at Berenberg
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 02/07/23 Berenberg
- Airbus downgraded to Sell from Hold at Berenberg
- 01/31/23 UBS
- Airbus downgraded to Sell from Buy at UBS
- 01/27/23 Kepler Cheuvreux
- Airbus downgraded to Reduce from Hold at Kepler Cheuvreux
- 01/26/23 Jefferies
- Airbus downgraded to Hold from Buy at Jefferies
- 03/28/23 DA Davidson
- First Citizens price target raised to $1,025 from $825 at DA Davidson
- 03/24/23 Morgan Stanley
- nCino price target lowered to $27 from $35 at Morgan Stanley
- 03/23/23 Raymond James
- Block short report doesn't include 'bombshell,' says Raymond James
- 03/29/23 Guggenheim
- McDonald's price target raised to $305 from $302 at Guggenheim
- 03/24/23 TD Cowen
- McDonald's price target raised to $299 from $293 at TD Cowen
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 03/08/23 Tigress Financial
- McDonald's price target raised to $330 from $320 at Tigress Financial
- 01/06/23 UBS
- Cano Health downgraded to Neutral from Buy at UBS
- 01/05/23 Wolfe Research
- Cano Health downgraded to Peer Perform from Outperform at Wolfe Research
- 12/13/22 Citi
- Citi opens 'positive Catalyst Watch' on Cano Health
- 12/13/22 BofA
- BofA resumes Cano Health at Underperform, sees potential more guidance cuts
- $41.97 /
+5.425 (+14.84%) - 04/03/23 BofA
- Teck Resources price target lowered to C$62 from C$65 at BofA
- 03/29/23 Morgan Stanley
- Teck Resources price target lowered to $42 from $44 at Morgan Stanley
- 03/14/23 Scotiabank
- Teck Resources price target raised to C$75 from C$70 at Scotiabank
- 03/02/23 Deutsche Bank
- Teck Resources price target raised to $46 from $42 at Deutsche Bank
- 03/30/23 Morgan Stanley
- Glencore price target lowered to 602 GBp from 670 GBp at Morgan Stanley
- 03/20/23 BofA
- Glencore upgraded to Buy from Neutral at BofA
- 03/20/23 UBS
- Glencore upgraded to Buy from Neutral at UBS
- 03/13/23 JPMorgan
- Glencore price target lowered to 620 GBp from 630 GBp at JPMorgan
- 03/09/23 Citi
- Apellis price target lowered to $88 from $91 at Citi
- 02/22/23 Raymond James
- Apellis price target raised to $139 from $123 at Raymond James
- 02/21/23 H.C. Wainwright
- H.C. Wainwright says Belite Bio opportunity intact despite GA treatment approval
- 02/21/23 BofA
- Apellis price target raised to $115 from $79 at BofA
- $73.71 /
-33.27 (-31.10%) - 04/03/23 Credit Suisse
- Ascendis Pharma downgraded at Credit Suisse after FDA find deficiencies in NDA
- 04/03/23 Credit Suisse
- Ascendis Pharma downgraded to Neutral from Outperform at Credit Suisse
- 04/03/23 Citi
- Citi opens '90-day upside Catalyst Watch' on Ascendis Pharma
- 03/07/23 BofA
- Ascendis Pharma has positive read-through from BridgeBio data, says BofA
- 04/03/23 Morgan Stanley
- Plug Power downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/05/23 Citi
- Plug Power price target lowered to $20 from $21 at Citi
- 03/02/23 Piper Sandler
- Plug Power price target lowered to $17 from $20 at Piper Sandler
- 03/02/23 KeyBanc
- Plug Power price target lowered to $25 from $31 at KeyBanc
- 04/03/23 Credit Suisse
- PPG price target raised to $128 from $118 at Credit Suisse
- 01/30/23 Deutsche Bank
- Axalta Coating upgraded to Buy from Hold at Deutsche Bank
- 01/30/23 Citi
- Axalta Coating upgraded to Buy from Neutral at Citi
- 01/23/23 Deutsche Bank
- PPG price target raised to $145 from $128 at Deutsche Bank
- 11/02/22 BWS Financial
- A10 Networks price target raised to $24 from $20 at BWS Financial
- 03/30/23 William Blair
- William Blair learned Verizon teaming with SAIC on big FAA contract
- 01/03/23 Morgan Stanley
- SAIC downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/09/22 Morgan Stanley
- SAIC price target raised to $108 from $99 at Morgan Stanley
- 12/08/22 Citi
- SAIC initiated with a Buy at Citi
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 11/14/22 Piper Sandler
- OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
- 01/31/23
- Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29
- 01/30/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79
- 02/02/23
- WWE reports Q4 EPS 45c, consensus 58c
- 11/02/22
- WWE reports Q3 EPS 49c, consensus 50c
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 02/08/23
- TotalEnergies reports Q4 EPS $2.97, consensus $3.03
- $194.03 /
-13.445 (-6.48%) - 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- $41.97 /
+5.425 (+14.84%) - 02/21/23
- Teck Resources reports Q4 adjusted EPS C$1.07 vs. C$2.54 a year ago
- 10/27/22
- Teck Resources reports Q3 adjusted EPS C$1.74 vs. C$1.88 last year
- 03/10/23
- Compugen considers exposure to SVB Financial as immaterial
- 01/19/23
- SVB Financial reports Q4 EPS $4.62, consensus $5.27
- 10/20/22
- SVB Financial reports Q3 EPS $7.21, consensus $6.95
- 02/02/23
- Shell reports Q4 adjusted EPS $1.39 vs. 83c last year
- 10/27/22
- Shell reports Q3 adjusted EPS $1.30 vs. 53c last year
- 04/03/23
- SAIC guides FY24 EPS $6.80-$7.00, consensus $7.48
- 04/03/23
- SAIC reports Q4 EPS $2.04, consensus $1.66
- 12/05/22
- SAIC raises FY23 adjusted EPS view to $7.05-$7.20 from $7.00-$7.20
- 12/05/22
- SAIC reports Q3 EPS $1.90, consensus $1.74
- 04/03/23
- PPG raises Q1 adjusted EPS view to $1.52-$1.58 from $1.10-$1.20, consensus $1.18
- 01/19/23
- PPG sees Q1 adjusted EPS $1.10-$1.20, consensus $1.36
- 01/19/23
- PPG Industries reports Q4 adjusted EPS $1.22, consensus $1.13
- 10/19/22
- PPG sees Q4 adjusted EPS $1.05-$1.20, consensus $1.25
- 03/01/23
- Plug Power sees FY23 revenue $1.4B, consensus $1.37B
- 03/01/23
- Plug Power reports Q4 revenue $220.7M, consensus $277.28M
- 03/01/23
- Notable companies reporting after market close
- 01/25/23
- Plug Power sees FY23 revenue at $1.4B, consensus $1.37B
- 03/31/23
- OncoCyte reports preliminary FY22 revenue $5.6M, consensus $5.94M
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
- 02/28/23
- Marqeta sees Q1 net revenue growth 26%-28%, consensus $214.08M
- 02/28/23
- Marqeta reports Q4 EPS (5c), consensus (9c)
- 11/09/22
- Marqeta sees Q4 revenue up 29%-31%, consensus $191M
- 01/31/23
- McDonald's reports Q4 EPS $2.59, consensus $2.46
- 10/27/22
- McDonald's reports Q3 adjusted EPS $2.68, consensus $2.58
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/22/23
- Intel backs Q1 EPS view (15c), consensus (15c)
- 02/16/23
- Tower Semiconductor not providing Q1 revenue guidance
- 01/26/23
- Intel sees Q1 EPS (15c), consensus 24c
- 01/26/23
- Intel reports Q4 EPS 10c, consensus 20c
- $117.73 /
+20.07 (+20.55%) - 02/28/23
- Heska sees FY23 revenue growth 8%-12%, consensus $278.56M
- 02/28/23
- Heska reports Q4 adjusted EPS 55c, consensus (4c)
- 11/08/22
- Heska reports Q4 non-GAAP EPS 41c, consensus (11c)
- 02/21/23
- HSBC reports FY22 EPS 74c vs. 62c last year
- 10/25/22
- HSBC reports Q3 EPS 10c vs. 17c last year
- 11/22/22
- Mechel announces amendment to agreement with Glencore
- 02/28/23
- First Solar sees FY23 EPS $7.00-$8.00, consensus $4.77
- 02/28/23
- First Solar reports Q4 EPS (7c), consensus (15c)
- 02/28/23
- Notable companies reporting after market close
- 10/27/22
- First Solar reports Q3 EPS (46c), consensus (27c)
- $155.44 /
-7.575 (-4.65%) - 02/22/23
- Extra Space Storage sees 2023 core FFO $8.30-$8.60 vs. $8.44 in 2022
- 02/22/23
- Extra Space Storage reports Q4 core FFO $2.09 vs. $1,91 a year ago
- 11/01/22
- Extra Space Storage narrows FY22 core FFO $8.30-$8.40 from $8.30-$8.50
- 11/01/22
- Extra Space Storage reports Q3 core FFO $2.21, consensus $2.18
- 02/28/23
- Endeavor Group sees Fy23 revenue $5.825B-$5.975B, consensus $5.81B
- 02/28/23
- Endeavor Group reports Q4 EPS (72c) vs (7c) last year
- 11/10/22
- Endeavor cuts FY22 revenue view to $5.235B-$5.325B, consensus $5.36B
- 11/10/22
- Endeavor reports Q3 EPS (4c), consensus 29c
- 02/16/23
- Airbus sees FY23 EBIT adjusted EUR 6B
- 02/16/23
- Airbus reports FY22 revenue EUR 58.8B, EBIT adjusted up 16% to EUR 5.6B
- 10/28/22
- Airbus reports Q3 revenue EUR 38.1B, EBIT adjusted EUR 3.5B
- 01/27/23
- Chevron reports Q4 adjusted EPS $4.09, consensus $4.38
- 01/26/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Chevron reports Q3 adjusted EPS $5.56, consensus $4.81
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- $107.11 /
+7.895 (+7.96%) - 02/02/23
- ConocoPhillips reports Q4 EPS $2.71, consensus $2.81
- 11/03/22
- ConocoPhillips reports Q3 EPS $3.60, consensus $3.44
- 11/02/22
- Notable companies reporting before tomorrow's open
- 03/01/23
- Cano Health sees FY23 revenue $3.1B-43.25B, consensus $3.26B
- 03/01/23
- Cano Health reports Q4 EPS (61c), consensus (13c)
- 11/09/22
- Cano Health lowers FY22 revenue view to $2.70B-$2.75B from $2.85B-$2.90B
- 11/09/22
- Cano Health reports Q3 EPS (23c), consensus (5c)
- 02/07/23
- BP reports Q4 EPS $1.59, consensus $1.67
- 11/01/22
- BP reports Q3 EPS $2.59, consensus $1.94
- 03/31/23
- BGC Partners says Q1 revenue impacted by recent turmoil across regional banks
- 02/27/23
- BGC Partners sees Q1 revenue $515M-$565M
- 02/27/23
- BGC Partners reports Q4 adjusted EPS 16c vs 17c last year
- 12/30/22
- BGC Partners sees Q4 adjusted earnings above midpoint of previous outlook
- 04/03/23
- A10 Networks backs prior FY23 double-digit growth view for EPS
- 04/03/23
- A10 Networks sees Q1 revenue $56 M-$58M, consensus $66.05M
- 02/07/23
- A10 Networks reports Q4 EPS 24c, two estimates 22c
- 11/01/22
- A10 Networks backs FY22 revenue growth target of 10%-12%
- $73.71 /
-33.27 (-31.10%) - 11/02/22
- Ascendis Pharma reports Q3 EPS ( EUR 3.03) vs. (EUR 1.47) last year
- 02/21/23
- Apellis reports Q4 EPS ($1.50), consensus ($1.57)
|
Syndicate
|
Oncocyte announced the… Oncocyte announced the entry into an agreement with certain members of the Company's board of directors, and several institutional and accredited investors, including Broadwood Capital, L.P., the Company's largest shareholder, relating to their purchase of an aggregate of up to 45,562,425 shares of its common stock at an offering price of: (i) $0.3544 per share to board members and (ii) $0.30168 per share to the other investors participating in the offering. The offering is intended to be priced 'at-the-market' for purposes of complying with applicable NASDAQ Listing Rules. The aggregate gross proceeds from the offering are expected to be up to $13,859,634 before deducting offering expenses payable by the Company. Oncocyte intends to use the net proceeds from the offering primarily to promote the development and commercialization of VitaGraft(TM), DetermaIO(TM) and DetermaCNI(TM). The company also intends to use approximately $3.7 million of the proceeds to repay a portion of its Series A Convertible Preferred Stock reducing future interest expense. ShowHide Related Items >><< - 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 11/14/22 Piper Sandler
- OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
- 03/31/23
- OncoCyte reports preliminary FY22 revenue $5.6M, consensus $5.94M
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
|
Earnings
| ShowHide Related Items >><< - 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 11/14/22 Piper Sandler
- OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
- 03/31/23
- OncoCyte reports preliminary Q4 revenue $1.1M, consensus $1.42M
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
|
Earnings
| ShowHide Related Items >><< - 03/31/23
- OncoCyte to delay filing Annual Report on Form 10-K
- 03/02/23
- OncoCyte appoints Riggs as President, CEO
- 02/22/23
- OncoCyte completes Razor Genomics transaction
- 12/16/22
- Oncocyte to eliminate president, COO, CSO positions
- 12/01/22 Lake Street
- OncoCyte downgraded to Hold from Buy at Lake Street
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral at Piper with revenue ramp slowing
- 11/17/22 Piper Sandler
- OncoCyte downgraded to Neutral from Overweight at Piper Sandler
- 11/14/22 Piper Sandler
- OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
- 11/10/22
- OncoCyte reports Q3 EPS (8c), consensus (11c)
|